BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Hong Kong

AXA Mind Health Study reveals more than half of Gen Z in Asia are suffering from poor mental health

While the COVID-19 pandemic has taken a heavy toll on mind health across society, the latest findings from the annual AXA Study of Mind Health and Wel...

March 20, 2023 | News

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial r...

March 15, 2023 | News

Akeso, based in Hong Kong, completes patient enrollment for Phase III clinical trial of Cadonilimab in the treatment of gastric cancer.

Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-sp...

March 14, 2023 | News

Antengene's ATG-022 Phase I CLINCH Trial for Solid Tumor Treatment Receives IND Approval in China

- Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Assoc...

March 14, 2023 | News

Prenetics Forms Advisory Board for Precision Oncology Strategy

Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Adviso...

March 02, 2023 | News

Keymed and Lepu Biopharma gain global exclusive license for CMG901 from AstraZeneca.

CMG901 is currently in a Phase I clinical trial for the treatment of Claudin 18.2-positive solid tumors. Preliminary results from the Phase 1 trial indicat...

February 24, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

February 03, 2023 | News

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...

February 02, 2023 | News

Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery

Dr. Jason Y.K. Chan, the co-founder of Agilis RoboticsTM , conducted the test with the firm's second-generation device on a live pig specimen and...

January 17, 2023 | News

MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe

With a commitment to building core tools and technology to lead life science, MGI Tech Co., Ltd. (or its affiliates, referred to as "MGI") is dedicated to ...

January 16, 2023 | News

Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023

Rade Drmanac, PhD, Chief Scientific Officer, announced "free three-month trial" program and "reagent rental leasing" program, giving customers the opportun...

January 11, 2023 | News

Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong

Luye Pharma has signed an agreement with Abacus Medicine Pharma Services (AMPS), an international healthcare and pharmaceutical services company, the terms...

January 10, 2023 | News

Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US

Fosun Pharma will have the right to commercialise serplulimab upon approval in the US, and Henlius will retain responsibility for development, manufacturin...

January 09, 2023 | News

Prenetics Acquires ACT Genomics

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genom...

December 16, 2022 | News

Stay Connected